Recommendations for selecting drug–drug interactions for clinical decision support

Author:

Tilson Hugh1,Hines Lisa E.2,McEvoy Gerald3,Weinstein David M.4,Hansten Philip D.5,Matuszewski Karl6,le Comte Marianne7,Higby-Baker Stefanie8,Hanlon Joseph T.9,Pezzullo Lynn2,Vieson Kathleen10,Helwig Amy L.11,Huang Shiew-Mei12,Perre Anthony13,Bates David W.14,Poikonen John15,Wittie Michael A.16,Grizzle Amy J.17,Brown Mary18,Malone Daniel C.18

Affiliation:

1. Public Health Leadership and Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

2. Performance Measurement, Pharmacy Quality Alliance, Springfield, VA

3. Drug Information, American Society of Health-System Pharmacists, Bethesda, MD

4. Metabolism, Interactions, and Genomics Group, Clinical Content, Lexi-Comp, Wolters-Kluwer Health, Cleveland, OH

5. Department of Pharmacy, University of Washington School of Pharmacy, Seattle, WA

6. Clinical and Editorial Knowledge Base Services, First Databank, San Francisco, CA

7. Drug Information Centre, Royal Dutch Association for the Advancement of Pharmacy, The Hague, Netherlands

8. Cerner Multum, Denver, CO

9. Division of Geriatrics and Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA

10. Diagnosis, Treatment and Care Decisions, Elsevier Clinical Solutions, Tampa, FL

11. Center for Quality Improvement and Patient Safety, Agency for Healthcare Research and Quality, Department of Health and Human Services, Washington, DC

12. Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD

13. New Patient Intake, Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA

14. Harvard Medical School, Boston, MA

15. University of Massachusetts, Lowell, MA

16. Office of the National Coordinator for Health Information Technology, Department of Health and Human Services, Washington, DC

17. Center for Health Outcomes and PharmacoEconomic Research, University of Arizona College of Pharmacy, Tucson, AZ

18. Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference66 articles.

1. Aspden P , WolcottJA, BootmanJL, Cronenwett, eds. Preventing medication errors: quality chasm series. www.iom.edu/Reports/2006/Preventing-Medication-Errors-Quality-Chasm-Series.aspx (accessed 2014 Apr 22).

2. Developing and implementing clinical decision support for use in a computerized prescriber-order-entry system;Chaffee;Am J Health-Syst Pharm,2010

3. ORCA: OpeRational ClassificAtion of drug interactions;Hansten;J Am Pharm Assoc,2001

4. Centers for Medicare and Medicaid Services. Eligible professional meaningful use core measures: measure 2 of 13. www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/2_Drug_Interaction_ChecksEP.pdf (accessed 2013 Jan 9)

5. The “meaningful use” regulation for electronic health records;Blumenthal;N Engl J Med,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3